全文获取类型
收费全文 | 12675篇 |
免费 | 784篇 |
国内免费 | 37篇 |
专业分类
耳鼻咽喉 | 113篇 |
儿科学 | 293篇 |
妇产科学 | 170篇 |
基础医学 | 1718篇 |
口腔科学 | 278篇 |
临床医学 | 1702篇 |
内科学 | 2785篇 |
皮肤病学 | 118篇 |
神经病学 | 1057篇 |
特种医学 | 538篇 |
外科学 | 1631篇 |
综合类 | 63篇 |
一般理论 | 4篇 |
预防医学 | 1049篇 |
眼科学 | 134篇 |
药学 | 882篇 |
中国医学 | 16篇 |
肿瘤学 | 945篇 |
出版年
2023年 | 78篇 |
2022年 | 129篇 |
2021年 | 252篇 |
2020年 | 182篇 |
2019年 | 305篇 |
2018年 | 337篇 |
2017年 | 250篇 |
2016年 | 295篇 |
2015年 | 332篇 |
2014年 | 464篇 |
2013年 | 674篇 |
2012年 | 1045篇 |
2011年 | 1040篇 |
2010年 | 601篇 |
2009年 | 536篇 |
2008年 | 813篇 |
2007年 | 918篇 |
2006年 | 818篇 |
2005年 | 867篇 |
2004年 | 722篇 |
2003年 | 616篇 |
2002年 | 647篇 |
2001年 | 86篇 |
2000年 | 66篇 |
1999年 | 102篇 |
1998年 | 159篇 |
1997年 | 119篇 |
1996年 | 112篇 |
1995年 | 99篇 |
1994年 | 84篇 |
1993年 | 70篇 |
1992年 | 58篇 |
1991年 | 48篇 |
1990年 | 44篇 |
1989年 | 47篇 |
1988年 | 34篇 |
1987年 | 23篇 |
1986年 | 28篇 |
1985年 | 34篇 |
1984年 | 33篇 |
1983年 | 41篇 |
1982年 | 39篇 |
1981年 | 22篇 |
1980年 | 23篇 |
1978年 | 15篇 |
1977年 | 15篇 |
1976年 | 11篇 |
1975年 | 15篇 |
1974年 | 13篇 |
1972年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
31.
32.
Sequence specificity of mutation induced by the anti-tumor drug cisplatin in the CHO aprt gene 总被引:5,自引:0,他引:5
Cis-diammine dichloroplatinum (cisplatin) is an effective anticancerdrug which forms adducts with DNA, in both bacterial and mammaliancells. It is suspected of producing tumors as well. To determinethe molecular nature of geneti alterations induced by cisplatin,we cloned and sequenced cisplatin-induced mutants in the adeninephosphoribosyl-transferase (aprt) gene of Cinese hamster ovary(CHO) cells. Mutation by cisplatin appears to be targeted asthe sites of mutation are consistent with the known bindingspecificity of cisplatin. Many mutations occur at or proximalto the sequence 5'-AGG-3' and 5'-GAG-3' and include transversions,transitions, frameshifts and short deletions and duplications.Several double changes were also observed. No major rearrangementswere recovered in our collection. At several locations, a numberof mutants were found to be clustered within a small targetregion, but unlike traditional hotspots, tese represent diversechanges occurring in a localized region of a few base pairs. 相似文献
33.
34.
Johannes M. A. Van Gerven Johan P. Boot Herman H. P. J. Lemkes Jaap A. Van Best PhD 《Documenta ophthalmologica. Advances in ophthalmology》1992,80(2):183-188
The morphological base for the impaired function of the blood retinal barrier was studied in 50 eyes of 10 insulin dependent and 21 non-insulin dependent patients with various levels of diabetic retinopathy. The permeability of the blood retinal barrier (PBRB) was determined by vitreous fluorophotometry with correction for autofluorescence, lenstransmission and non-protein bound plasma fluorescein concentration. Morphological abnormalities of diabetic retinopathy assessed by fundus photography and fluorescein angiography were individually scored on a decimal scale and related to the PBRB by multiple regression analysis. The Pbrb was not correlated to morphological abnormalities of non-proliferative retinopathy [(1) microaneurysms, (2) hard exudates, (3) soft exudates, (4) intraretinal hemorrhages, (5) fluorescein leakage, and (6) capillary closure, p > 0.3]. The PBRB was correlated to morphological abnormalities of (pre)proliferative retinopathy [(1) intraretinal microvascular abnormalities (Sirma) and (2) new vessels (Sneo): pbrb = A – B.SIRMA – C.Sneo with PBRB in nm/sec, A = 1.5 ± 0.5, B = 0.9 ± 0.2 and C = 1.7 ± 0.4, R2 = 0.65, p < 0.0001]. It can be concluded that the increased blood retinal barrier permeability in diabetic patients is mainly due to (pre)proliferative abnormalities and not to non-proliferative abnormalities. 相似文献
35.
36.
M Herz V Arora B N Campaigne H E Scholtz M A Potgieter W Mollentze 《Suid-Afrikaanse tydskrif vir geneeskunde》2003,93(3):219-223
OBJECTIVE: To compare the effects of Humalog Mix25 (Humalog Mix75/25 in the USA) (Mix25) and human insulin 30/70 (30/70) on the 24-hour inpatient plasma glucose (PG) profile in patients with type 2 diabetes mellitus (T2DM). DESIGN: A randomised, open-label, 8-week crossover study. Study insulins were injected twice daily, 5 minutes before breakfast and dinner. SETTING: Four-week outpatient (dose-adjustment) treatment phase, and 3-day inpatient (test) phase. PATIENTS: Twenty-five insulin-treated patients with T2DM (ages 40-66 years), mean (+/- standard error of the mean) (SEM) HbA1c 7.7% +/- 0.23%, and body mass index (BMI) 29.3 +/- 0.83 kg/m2. OUTCOME MEASURES: 24-hour PG profiles, PG excursions after meals, PG area under the curve (AUC), and 30-day hypoglycaemia rate. RESULTS: The 2-hour PG excursions following breakfast (5.5 +/- 0.34 v. 7.2 +/- 0.34 mmol/l, p = 0.002) and dinner (2.4 +/- 0.27 v. 3.4 +/- 0.27 mmol/l, p = 0.018) were smaller with Mix25 than with 30/70. PG AUC between breakfast and lunch was smaller with Mix25 than with 30/70 (77.6 +/- 3.8 v. 89.5 +/- 4.3 mmol/h/ml, p = 0.001). PG AUC between lunch and dinner, dinner and bedtime, and bedtime and breakfast did not differ between treatments. Pre-meal and nocturnal PG were comparable. The postprandial insulin requirement for lunch meals was supplied equally by the two insulin treatments. The thirty-day hypoglycaemia rate was low (Mix25 0.049 +/- 0.018 v. 30/70 0.100 +/- 0.018 episodes/patient/30 days, p = 0.586) for both treatments. CONCLUSION: In patients with T2DM, Mix25 improved the 24-hour PG profile with lower postprandial PG excursions than with human insulin 30/70. 相似文献
37.
Antibody Response Against the Glomerular Basement Membrane Protein Agrin in Patients with Transplant Glomerulopathy 总被引:3,自引:0,他引:3
Simone A. Joosten Yvo W.J. Sijpkens Vanessa van Ham Leendert A. Trouw Johan van der Vlag Bert van den Heuvel Cees van Kooten Leendert C. Paul 《American journal of transplantation》2005,5(2):383-393
Chronic allograft nephropathy (CAN) of renal allografts is still the most important cause of graft loss. A subset of these patients have transplant glomerulopathy (TGP), characterized by glomerular basement membrane (GBM) duplications, but of unknown etiology. Recently, a role for the immune system in the pathogenesis of TGP has been suggested. In 11 of 16 patients with TGP and in 3 of 16 controls with CAN in the absence of TGP we demonstrate circulating antibodies reactive with GBM isolates. The presence of anti-GBM antibodies was associated with the number of rejection episodes prior to diagnosis of TGP. Sera from the TGP patients also reacted with highly purified GBM heparan sulphate proteoglycans (HSPG). Indirect immunofluorescence with patient IgG showed a GBM-like staining pattern and colocalization with the HSPGs perlecan and especially agrin. Using patient IgG, we affinity purified the antigen and identified it as agrin. Reactivity with agrin was found in 7 of 16 (44%) of patients with TGP and in 7 of 11 (64%) patients with anti-GBM reactivity. In conclusion, we have identified a humoral response against the GBM-HSPG agrin in patients with TGP, which may play a role in the pathogenesis of TGP. 相似文献
38.
We are grateful to Dr Parmar for raising this important issue.Dr Parmar appears to be under the impression that our studysample consisted of elderly men with hypertension. 相似文献
39.
Liviu Feller Neil H Wood Johan Lemmer 《Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics》2007,104(4):455-460
The use of highly active antiretroviral therapy (HAART) in the management of human immunodeficiency virus (HIV) infection has resulted paradoxically in the worsening of clinical symptoms of previously subclinical infections, such as herpes zoster (HZ), herpes simplex, angular cheilitis, warts, tuberculosis, hepatitis B and C, cytomegalovirus retinitis, and others, as a result of substantial reconstitution of the host's immune responses. This phenomenon is referred to as immune reconstitution inflammatory syndrome (IRIS). It may affect up to 32% of HIV-seropositive subjects within a wide range of time after the initiation of HAART, but mainly after 8-12 weeks. Mucocutaneous HZ accounts for 7%-12% of the diseases associated with HIV infection that become worse again when the subject's immunity improves from the administration of HAART. It usually occurs after 4 weeks from the initiation of HAART, and under these circumstances the clinical symptoms and natural course of mucocutaneous HZ are similar to those in HIV-seropositive subjects who do not manifest IRIS. 相似文献
40.